Home›Articles›An approval on one trial, a withdrawal after anotherArticleAn approval on one trial, a withdrawal after anotherArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnMelphalan flufenamide, Drugs and Medicinal Substances Well-attested SourcesMelphalan flufenamide (Wikipedia)HistoryQuote, HistoryIn October 2021, Oncopeptides AB announced the withdrawal of Pepaxto from the US market after the OCEAN trial's data showed no improvement in terms of overall survival versus pomalidomide in the ITT groupView the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.